These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6109319)

  • 1. Structural requirements for antibacterial activity and beta-lactamase stability of 7 beta-arylmalonylamino-7 alpha-methoxy-1-oxacephems.
    Yoshida T
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):231-7. PubMed ID: 6109319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antibacterial activity of 1-oxacephem derivatives.
    Narisada M; Yoshida T; Onoue H; Ohtani M; Okada T; Nagata W
    J Antibiot (Tokyo); 1982 Apr; 35(4):463-82. PubMed ID: 6212566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Oxacephalosporins: enhancement of beta-lactam reactivity and antibacterial activity.
    Murakami K; Takasuka M; Motokawa K; Yoshida T
    J Med Chem; 1981 Jan; 24(1):88-93. PubMed ID: 6451699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxalactam: the first of a new class of beta-lactam antibiotics.
    Webber JA; Yoshida T
    Rev Infect Dis; 1982; 4 Suppl():S496-500. PubMed ID: 6218558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the 7 alpha-methoxy and side-chain carboxyl of moxalactam in beta-lactamase stability and antibacterial activity.
    Murakami K; Yoshida T
    Antimicrob Agents Chemother; 1981 Jan; 19(1):1-7. PubMed ID: 6454378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on oxacephems, an artificial type of beta-lactam antibiotics].
    Nagata W; Narisada M; Yoshioka M; Yoshida T; Onoue H
    Yakugaku Zasshi; 1991 Feb; 111(2):77-102. PubMed ID: 2056448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation.
    Yoshida T; Matsuura S; Mayama M; Kameda Y; Kuwahara S
    Antimicrob Agents Chemother; 1980 Mar; 17(3):302-12. PubMed ID: 6448572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of moxalactam to beta-lactamase.
    Richmond MH
    Rev Infect Dis; 1982; 4 Suppl():S522-6. PubMed ID: 6218561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics.
    Vuye A
    Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antibacterial activity of T-1982, a new semisynthetic cephamycin antibiotic.
    Tai M; Fukuoka Y; Yotsuji A; Kumano K; Takahata M; Mikami H; Yasuda T; Saikawa I; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Nov; 22(5):728-34. PubMed ID: 6983861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
    Neu HC; Chin NX
    Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beta-lactamase stability of a novel beta-lactam antibiotic containing a 7 alpha-methoxyoxacephem nucleus.
    Richmond MH
    J Antimicrob Chemother; 1980 Jul; 6(4):445-53. PubMed ID: 6448832
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and structure-activity relationship of new cephalosporins with amino heterocycles at C-7. Dependence of the antibacterial spectrum and beta-lactamase stability on the pKa of the C-7 heterocycle.
    Jung F; Delvare C; Boucherot D; Hamon A; Ackerley N; Betts MJ
    J Med Chem; 1991 Mar; 34(3):1110-6. PubMed ID: 2002452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.
    Neu HC
    Antimicrob Agents Chemother; 1974 Aug; 6(2):170-6. PubMed ID: 15828188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of 7 alpha-hydroxyethyl-1-oxacephem derivatives.
    Nishimura S; Sasaki H; Yasuda N; Matsumoto Y; Kamimura T; Sakane K; Takaya T
    J Antibiot (Tokyo); 1989 Jul; 42(7):1124-32. PubMed ID: 2502525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semisynthetic beta-lactam antibiotics. IV. Synthesis and antibacterial activity of new ureidocephalosporin and ureidocephamycin derivatives containing a catechol moiety or its acetate.
    Ohi N; Aoki B; Shinozaki T; Moro K; Kuroki T; Noto T; Nehashi T; Matsumoto M; Okazaki H; Matsunaga I
    Chem Pharm Bull (Tokyo); 1987 May; 35(5):1903-9. PubMed ID: 3664799
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and substituent effects on antibacterial activity, alkaline hydrolysis rates, and infrared absorption frequencies of some cephem analogues related to latamoxef (moxalactam).
    Narisada M; Yoshida T; Ohtani M; Ezumi K; Takasuka M
    J Med Chem; 1983 Nov; 26(11):1577-82. PubMed ID: 6631914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Moxalactam: a new group of beta-lactams].
    Fourtillan JB
    Sem Hop; 1983 Jun; 59(26):1947-8. PubMed ID: 6310783
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure activity relationships among the monobactams.
    Bonner DP; Sykes RB
    J Antimicrob Chemother; 1984 Oct; 14(4):313-27. PubMed ID: 6389473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of cefotetan to Gram-negative beta-lactamases.
    Cocuzza G; Blandino G; Mattina R
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():139-45. PubMed ID: 6601653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.